Hops BioSciences, a startup spun off from Jeonbuk National University, has been selected for the Daonda Program, a global corporate collaboration initiative. The university said that through the program, the company will pursue an artificial intelligence (AI) transformation strategy aimed at integrating AI throughout the drug development process. The program is jointly operated by the Ministry of SMEs and Startups, the Korea Institute of Startup and Entrepreneurship Development and Dassault Systèmes, a global French software company. The initiative supports promising Korean startups in enhancing their technological competitiveness by leveraging Dassault Systèmes’ technologies, expertise and global network. “With this selection, we aim to transform into an AX (AI transformation) company by integrating AI technologies throughout the drug development process and dramatically reducing development time and costs,” said Lee Jeong-hwan, CEO of Hops BioSciences and a professor in the university’s Department of Biological Sciences. He added, “We plan to accelerate our growth by expandi
Pangram raised $9 million to expand AI detection into images